Scientists Link Genetic 'Typos' To Schizophrenia

An ambitious multi-million dollar Canadian project to identify hundreds of
genes essential to communication between brain cells has led to the
discovery that random mutations not inherited from either parent play a role
in schizophrenia.

The scientists also found the same kind of genetic glitches in patients with
autism, which adds to the growing understanding of the genetic overlap
between the two disorders.

De novo point mutations, as they are called, are almost like typos. One
letter in the genetic code gets changed for another. Two or three of them
are present in everyone at birth, and most of the time, they are harmless.
But researchers at the University of Montreal have found that if they occur
on genes that help neurons connect, they can predispose people to develop
schizophrenia or autism.

The work could lead to prenatal screening for both disorders, or for new,
more personalized approaches to treating people depending upon their genetic
profile.

The findings, published in the American Journal of Human Genetics, also help
explain why rates of schizophrenia remain relatively stable around the
world, even though people with the disorder are less likely to have children
and pass on their genes to the next generation.

“It is a new way to think about how these diseases can develop,” says Guy
Rouleau, senior author on the paper.

It still unclear what percentage of cases of autism or schizophrenia are
caused by or related to de novo mutations. It may be as low as 5 per cent or
high as high as 50 per cent, says Dr. Rouleau. That’s because there are an
estimated 4,000 genes involved in the complicated communication between
brain cells, and this study looked for mutations in only 400 genes.

Before new screening tests can be developed, Dr. Rouleau says researchers
have to learn how likely it is that someone with one of these kinds of
mutations would develop either disorder.

“There are always confounding environmental factors. Will it lead to disease
in 25 per cent of people, or 85 per cent of people?” he says.

The study did, however, find that random mutations to the same gene can lead
to schizophrenia in one person and autism in another, fuelling the notion
that the same genes may be involved in different neuropsychiatric disorders.
It’s an idea that researchers are increasingly focusing on, says Stephen
Scherer, a senior scientist at the Hospital for Sick Children in Toronto.

“It is really going to dominate in the next few years.”

Schizophrenia affects one in 100 Canadians, and can cause disorganized
thinking, paranoia hallucinations and social withdrawal.

One in every 110 children have autism or a related condition, known under
the catch-all term autism spectrum disorders, which affect communication and
social interaction. In severe cases, children can’t speak.

The findings fit with the emerging international consensus that
schizophrenia has a wide variety of genetic as well as environmental risk
factors, says Philip Seeman, a University of Toronto researcher known for
his groundbreaking work on the biology of disease. Environmental factors
including brain injury at birth or the use of street drugs, he says.

They also answer an important question, says Simon Fraser University’s
Bernard Crespi.

“This is showing us the first clear picture of new, quite bad genes entering
the human genome and what are they and what kind of effects they have.”

Dr. Rouleau is the head of the Synapse 2 Disease project, funded by federal
and provincial agencies, which has spent $10-million and several years
identifying more than 400 genes that play a role in communication between
brain cells, which occurs at the junction, or synapse, between two neurons.

New technology is making it faster and cheaper to identify the rest of the
estimated 4,000 genes involved, he says.

This study involved 285 volunteers with either autism or schizophrenia and
their parents. It found that 15 of the patients, roughly half with each
disorder, had random, damaging mutations to one of the 400 genes

http://www.theglobeandmail.com/life/health/scientists-link-genetic-typos-to-schizophrenia/article1687069/

-- 
You received this message because you are subscribed to the Google
Groups "Mental Health Advocacy (News 'N Views) India" group.
To post to this group, send email to [email protected]
To unsubscribe from this group, send email to
[email protected]
For more options, visit this group at
http://groups.google.com/group/MhaNewsViewsIndia?hl=en
-------------
Affiliated Groups :  MENTAL HEALTH ADVOCACY INDIA
[email protected]
Discussions on mental health law / policy / plan monitoring / human rights etc 
[email protected]
India-specific news and views related to mental health
[email protected]
Information and support to carers of people with mental health issues
[email protected]
Mutual support and sharing of experiential knowledge, skills and social 
learning amongst peers

Reply via email to